Invesco Biotechnology & Genome ETF
PBE
PBE
87 hedge funds and large institutions have $165M invested in Invesco Biotechnology & Genome ETF in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 8 closing their positions.
Holders
87
Holders Change
+5
Holders Change %
+6.1%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
24
Reduced
22
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
QA
1
Quantitative Advantage
Minnetonka,
Minnesota
|
$6.06M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$22.4M |
3 |
3
Jane Street
New York
|
$2.46M |
4 |
4
UBS Group
Zurich,
Switzerland
|
$21M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$1.64M |